Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01238861 · ClinicalTrials.gov registry record · Phase 2

Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma

A Phase 2 study of Asthma, sponsored by MedImmune.

Completed
Registry status
Phase 2
Development phase
964
Enrollment target
20
Study locations

NCT01238861 is a Phase 2 study of Asthma that has completed, run by MedImmune. The registered enrollment target is 964 participants, below the 1,561-participant average among 374 other Asthma trials with a reported enrollment target (38% lower). The trial reports 20 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01238861, a Phase 2 study of Asthma, has completed, sponsored by MedImmune.

COMPLETED
Registry status
Phase 2
Development phase
964 participants
Enrollment target
20
Study locations

Study Summary

The primary objective of the study is to evaluate the effect of multiple-dose subcutaneous administrations of MEDI-563 on adults with uncontrolled asthma.

Conditions Studied

Asthma

Interventions

  • OTHER Placebo
  • BIOLOGICAL Benralizumab 2 mg
  • BIOLOGICAL Benralizumab 20 mg
  • BIOLOGICAL Benralizumab 100 mg

Study Locations (20)

California

  • Research Site - Los Angeles
  • Research Site - Orange
  • Research Site - San Diego
  • Research Site - Stockton

Colorado

  • Research Site - Colorado Springs
  • Research Site - Denver

Florida

  • Research Site - Kissimmee
  • Research Site - Tampa

Alabama

  • Research Site - Birmingham

Connecticut

  • Research Site - Waterbury

Georgia

  • Research Site - Stockbridge

Illinois

  • Research Site - Normal

Maryland

  • Research Site - Baltimore

Trial Details

FieldValue
Enrollment Target 964 participants
Start Date 2010-12
Est. Completion 2013-08
Phase Phase 2

Sponsor

MedImmune

210 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01238861

The ClinicalTrials.gov registry entry for NCT01238861 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 964 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,561-participant average among 374 other Asthma trials with a reported enrollment target (38% lower). The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.

NCT01238861 reports 20 study locations spanning 15 distinct geographic areas - top geographies include California, Colorado, Florida.

Frequently Asked Questions

What is clinical trial NCT01238861 about?

NCT01238861 is a clinical study titled "Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma". The primary objective of the study is to evaluate the effect of multiple-dose subcutaneous administrations of MEDI-563 on adults with uncontrolled asthma.

What is the current status of trial NCT01238861?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 964 participants. The study started on 2010-12. Estimated completion is 2013-08.

What conditions does trial NCT01238861 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT01238861?

The interventions under investigation include: Placebo (OTHER), Benralizumab 2 mg (BIOLOGICAL), Benralizumab 20 mg (BIOLOGICAL), Benralizumab 100 mg (BIOLOGICAL).

Who is sponsoring clinical trial NCT01238861?

This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01238861 being conducted?

This trial has 20 study locations across Alabama, California, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Asthma

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.